39 /100
MEDIUM RISK
Score updated Jul 13, 2026

STK — Columbia Seligman Premium Technology Growth Fund Dilution Risk Tracker

Track STK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track STK — Get alerts when the score changes →

As of July 13, 2026, Columbia Seligman Premium Technology Growth Fund (STK) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Columbia Seligman Premium Technology Growth Fund has a market capitalization of $984.80M, 17.66M shares outstanding, 79 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for STK.
🔔 Track STK — Get forecast alerts →

💹 Market Data

Market Cap$984.80M
Shares Outstanding17.66M
FloatN/A
CashN/A
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 21.0% shares (2026Q1 vs prior)
79 institutional holders · 3.71M shares
#1 MORGAN STANLEY 945.5K shares
#2 WELLS FARGO & COMPANY/MN 404.3K shares
#3 Janney Montgomery Scott LLC 306.5K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest10.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for STK Shareholders

Columbia Seligman Premium Technology Growth Fund (STK) has a DilutionScore of 39/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for STK shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for STK in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for STK alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track STK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for STK
📊 STK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 STK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.